GENE CELL INC
10KSB/A, EX-27, 2000-06-02
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: GENE CELL INC, 10KSB/A, EX-16, 2000-06-02
Next: GENE CELL INC, 10QSB/A, 2000-06-02



<TABLE> <S> <C>

<ARTICLE> 5
<CIK> 0001096637
<NAME> GENE CELL, INC.

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-END>                               DEC-31-1999
<CASH>                                          28,670
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0
<PP&E>                                         208,561
<DEPRECIATION>                                  97,017
<TOTAL-ASSETS>                                 158,536
<CURRENT-LIABILITIES>                           67,355
<BONDS>                                              0
                                0
                                          0
<COMMON>                                        17,778
<OTHER-SE>                                      67,841
<TOTAL-LIABILITY-AND-EQUITY>                   158,536
<SALES>                                              0
<TOTAL-REVENUES>                                11,991
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                               528,991
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              30,672
<INCOME-PRETAX>                               (547,742)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                           (547,742)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (547,742)
<EPS-BASIC>                                       (.03)
<EPS-DILUTED>                                     (.03)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission